Causes of prostate cancer
To test or not to test with prostate-specific antigen (PSA)?
For professional support, we’re here for you.
We offer services that can help your doctor diagnose prostate cancer and determine the most appropriate treatment.
- Total PSA: The level of PSA in the blood indicates an increase in the size of the prostate gland, which may be physiological in origin or associated with inflammation or cancer.
- Free and total PSA report: Measuring the ratio of free PSA to total PSA is useful in assessing the risk of prostate cancer in patients who have a slightly elevated PSA level.
- Prostate biopsy: This procedure involves microscopic analysis of suspect samples of tissue from the prostate.
- Prostate MRI: The MRI is the test of choice for viewing the prostate and detecting any anomalies.
- Canadian Cancer Society. “What is prostate cancer?” https://www.cancer.ca/en/cancer-information/cancer-type/prostate/prostate-cancer/?region=on (accessed on June 17, 2021).
- Brenner, Darren R. et al. “Estimations prévues du cancer au Canada en 2020,” CMAJ (March 2, 2020): Vol. 192, https://cdn.cancer.ca/-/media/files/research/cancer-statistics/2020-statistics/canadian-cancer-statistics/2020-incidence-and-mortality-estimates-for-other-cancers/res-cancerstatistics-canadiancancerstatistics-estimations-prvues-du-cancer-au-canada-en-2020.pdf?rev=b9b9832340fa43a9a538ed60e2f0ea93&hash=98562D8B30CC34421600F2B8E516D43F (accessed on June 17, 2021).
- Mayo Clinic. “Prostate Cancer,” https://www.mayoclinic.org/diseases-conditions/prostate-cancer/symptoms-causes/syc-20353087 (accessed on June 17, 2021).
- Canadian Cancer Society. “Recommendations and Guidelines,” https://www.prostatecancer.ca/Supporting-You/Health-Professionals/Recommendations-and-Guidelines?lang=en-CA (accessed on June 17, 2021).
- Collège des médecins du Québec. “Le dépistage du cancer de la prostate,” http://www.cmq.org/publications-pdf/p-3-2013-09-01-fr-depistage-cancer-de-la-prostate.pdf (accessed on June 17, 2021).
Dr Nicolas Tétreault, Clinical Biochemist, Ph.D., FCACB, CSPQ
Scientific and Innovation DirectorLinkedIn
Having practiced in the public and private networks while constantly monitoring the evolution of biomedical laboratory medicine, Dr. Tétreault, a clinical biochemist, stands out for his innovative vision and unique expertise in the Canadian, American and European markets. He teaches at the Université de Montréal and regularly publishes texts intended for the general public or experts in the field.